Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Hilal A. Parray"'
Autor:
Dinesh Bure, Muzamil A. Makhdoomi, Rakesh Lodha, Somi Sankaran Prakash, Rajesh Kumar, Hilal A. Parray, Ravinder Singh, Sushil K. Kabra, Kalpana Luthra
Publikováno v:
Viruses, Vol 7, Iss 2, Pp 590-603 (2015)
The success of highly active antiretroviral therapy (HAART) is challenged by the emergence of resistance-associated mutations in human immunodeficiency virus-1 (HIV-1). In this study, resistance associated mutations in the reverse transcriptase (RT)
Externí odkaz:
https://doaj.org/article/4052783da447435a90da95ea0a9f9a6e
Autor:
Irfan A. Rather, Hilal A. Parray, Jameel B. Lone, Woon K. Paek, Jeongheui Lim, Vivek K. Bajpai, Yong-Ha Park
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 7 (2017)
Dengue is currently the highest and rapidly spreading vector-borne viral disease, which can lead to mortality in its severe form. The globally endemic dengue poses as a public health and economic challenge that has been attempted to suppress though a
Externí odkaz:
https://doaj.org/article/470d3041c0ac47b5a325c66b2b98944e
Publikováno v:
Functionalized Carbon Nanotubes for Biomedical Applications. :75-94
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abc56d49805cff449cd6430637987f6b
https://doi.org/10.1002/9781119905080.ch4
https://doi.org/10.1002/9781119905080.ch4
Autor:
Adarsh Kumar, Chiranjivi, Dilip, Kumar, Rajesh, Kumar, Hilal Ahmad, Parray, Shubbir, Ahmed, Chandra Sekhar, Kumar, Tripti, Shrivastava, Manidipa, Banerjee, B V Venkataram, Prasad, Supratik, Das
Publikováno v:
International Journal of Biological Macromolecules. 217:19-26
Dengue virus is transmitted by Aedes mosquitoes and dengue is endemic in many regions of the world. Severe dengue results in complications that may lead to death. Although some vaccine candidates are in clinical trials and one vaccine Dengvaxia, with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bd7751e771f38544389f32035133585
https://doi.org/10.1016/j.ijbiomac.2022.07.028
https://doi.org/10.1016/j.ijbiomac.2022.07.028
Autor:
Ritika Khatri, Hilal Ahmad Parray, Ashish Kumar Agrahari, Zaigham Abbas Rizvi, Rachel Kaul, Sneha Raj, Shailendra Asthana, Shailendra Mani, Sweety Samal, Amit Awasthi, Shubbir Ahmed
Publikováno v:
International Journal of Biological Macromolecules. 209:1359-1367
The COVID-19 pandemic caused by SARS-CoV-2 has a significant burden on the economy and healthcare around the world. Vaccines are the most effective tools to fight infectious diseases by containing the spread of the disease. The current vaccines again
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66307eba2787b8f5e0fe3084edf250f7
https://doi.org/10.1016/j.ijbiomac.2022.04.148
https://doi.org/10.1016/j.ijbiomac.2022.04.148
Autor:
Supratik Das, Hilal Ahmad Parray, Adarsh Kumar Chiranjivi, Manish Bansal, Deepak Kumar Rathore, Rajesh Kumar, Sweety Samal
Efficiently cleaved HIV-1 Envs are the closest mimics of functional Envs as they specifically expose only bNAb (broadly neutralizing antibody) epitopes and not non-neutralizing ones, making them suitable for developing vaccine immunogens. We have pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d46c7895e12f637dec563e7a5e01c46
https://doi.org/10.21203/rs.3.rs-2245790/v1
https://doi.org/10.21203/rs.3.rs-2245790/v1
Autor:
Chandra Shekhar Kumar, Balwant Singh, Zaigham Abbas Rizvi, Hilal Ahmad Parray, Jitender Kumar Verma, Sukanya Ghosh, Amitabha Mukhopadhyay, Amit Awasthi, Tripti Shrivastava, Manidipa Banerjee
Publikováno v:
ACS infectious diseases. 8(10)
The engineering of virus-like particles (VLPs) is a viable strategy for the development of vaccines and for the identification of therapeutic targets without using live viruses. Here, we report the generation and characterization of quadruple-antigen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::109cef9a3500a52e9f928e17669bee82
https://pubmed.ncbi.nlm.nih.gov/36129193
https://pubmed.ncbi.nlm.nih.gov/36129193
Autor:
Vanshika Singh, Sweety Samal, Ritika Khatri, Kalpana Luthra, Tripti Shrivastava, Chandresh Sharma, Rajesh Kumar, Shubbir Ahmed, Praveenkumar Murugavelu, Reshma Perween, Subrata Sinha, Hilal Ahmad Parray, Shivangi Shukla
Publikováno v:
Applied Microbiology and Biotechnology
The route of administration of a therapeutic agent has a substantial impact on its success. Therapeutic antibodies are usually administered systemically, either directly by intravenous route, or indirectly by intramuscular or subcutaneous injection.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3931f4909df1a84dc4699cdce5bed846
https://doi.org/10.1007/s00253-021-11488-4
https://doi.org/10.1007/s00253-021-11488-4
Autor:
Sonal Garg, Nisha Raj, Asha Lukose, Deepti Jamwal, Hilal Ahmed Parray, Sandeep Kumar, Samridhi Dhyani, Kamini Jakhar, Sudipta Sonar, Mahima Tiwari, null Reema, Shailendra Mani, Sankar Bhattacharyya, Chandresh Sharma, Tripti Shrivastava, Rajesh Kumar
Publikováno v:
3 Biotech. 12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::092aa2833bbc253a672239c47bb65c36
https://doi.org/10.1007/s13205-022-03272-6
https://doi.org/10.1007/s13205-022-03272-6
Autor:
Hilal Ahmad Parray, Naveen Narayanan, Sonal Garg, Zaigham Abbas Rizvi, Tripti Shrivastava, Sachin Kushwaha, Janmejay Singh, Praveenkumar Murugavelu, Anbalagan Anantharaj, Farha Mehdi, Nisha Raj, Shivam Singh, Jyotsna Dandotiya, Asha Lukose, Deepti Jamwal, Sandeep Kumar, Adarsh K. Chiranjivi, Samridhi Dhyani, Nitesh Mishra, Sanjeev Kumar, Kamini Jakhar, Sudipta Sonar, Anil Kumar Panchal, Manas Ranjan Tripathy, Shirlie Roy Chowdhury, Shubbir Ahmed, Sweety Samal, Shailendra Mani, Sankar Bhattacharyya, Supratik Das, Subrata Sinha, Kalpana Luthra, Gaurav Batra, Devinder Sehgal, Guruprasad R. Medigeshi, Chandresh Sharma, Amit Awasthi, Pramod Kumar Garg, Deepak T. Nair, Rajesh Kumar
Publikováno v:
PLoS pathogens. 18(12)
The emergence of new variants of SARS-CoV-2 necessitates unremitting efforts to discover novel therapeutic monoclonal antibodies (mAbs). Here, we report an extremely potent mAb named P4A2 that can neutralize all the circulating variants of concern (V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03e1596e9b50e3d75b921ab679a4887f
https://pubmed.ncbi.nlm.nih.gov/36508467
https://pubmed.ncbi.nlm.nih.gov/36508467